Ken W. Marshall - Net Worth and Insider Trading
Ken W. Marshall Net Worth
The estimated net worth of Ken W. Marshall is at least $3,887 dollars as of 2025-05-07. Ken W. Marshall is the Commercial Leader of Aquestive Therapeutics Inc and owns about 1,445 shares of Aquestive Therapeutics Inc (AQST) stock worth over $3,887. Details can be seen in Ken W. Marshall's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ken W. Marshall has not made any transactions after 2018-11-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ken W. Marshall
Ken W. Marshall Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ken W. Marshall owns 1 companies in total, including Aquestive Therapeutics Inc (AQST) .
Click here to see the complete history of Ken W. Marshall’s form 4 insider trades.
Insider Ownership Summary of Ken W. Marshall
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| AQST | Aquestive Therapeutics Inc | 2018-11-21 | Commercial Leader |
Ken W. Marshall Latest Holdings Summary
Ken W. Marshall currently owns a total of 1 stock. Ken W. Marshall owns 1,445 shares of Aquestive Therapeutics Inc (AQST) as of November 21, 2018, with a value of $3,887.
Latest Holdings of Ken W. Marshall
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics Inc | 2018-11-21 | 1,445 | 2.69 | 3,887 |
Holding Weightings of Ken W. Marshall
Ken W. Marshall Form 4 Trading Tracker
According to the SEC Form 4 filings, Ken W. Marshall has made a total of 0 transactions in Aquestive Therapeutics Inc (AQST) over the past 5 years. The most-recent trade in Aquestive Therapeutics Inc is the acquisition of 1,445 shares on November 21, 2018, which cost Ken W. Marshall around $14,667.
Insider Trading History of Ken W. Marshall
- 1
Ken W. Marshall Trading Performance
GuruFocus tracks the stock performance after each of Ken W. Marshall's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ken W. Marshall is -43.84%. GuruFocus also compares Ken W. Marshall's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ken W. Marshall within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ken W. Marshall's insider trading performs compared to the benchmark.
Performance of Ken W. Marshall
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -36.3 | | | | | |
| Relative Return to S&P 500(%) | -27.5 | | | | | |
Ken W. Marshall Ownership Network
Ownership Network List of Ken W. Marshall
Ownership Network Relation of Ken W. Marshall
Ken W. Marshall Owned Company Details
What does Aquestive Therapeutics Inc do?
Who are the key executives at Aquestive Therapeutics Inc?
Ken W. Marshall is the Commercial Leader of Aquestive Therapeutics Inc. Other key executives at Aquestive Therapeutics Inc include SVP & Operations Cassie Jung , director & Chief Innovation/Tech Officer Alexander Mark Schobel , and Chief Medical Officer Carl N Kraus .
Aquestive Therapeutics Inc (AQST) Insider Trades Summary
Over the past 18 months, Ken W. Marshall made no insider transaction in Aquestive Therapeutics Inc (AQST). Other recent insider transactions involving Aquestive Therapeutics Inc (AQST) include a net sale of 75,000 shares made by Alexander Mark Schobel , and a net sale of 44 shares made by Cassie Jung .
In summary, during the past 3 months, insiders sold 0 shares of Aquestive Therapeutics Inc (AQST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 75,044 shares of Aquestive Therapeutics Inc (AQST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 75,044 shares.
Aquestive Therapeutics Inc (AQST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aquestive Therapeutics Inc Insider Transactions
Ken W. Marshall Mailing Address
Above is the net worth, insider trading, and ownership report for Ken W. Marshall. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Ken W. Marshall's mailing address is: Warren Nj 07059.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
